“This is the first randomised controlled trial demonstrating that treatment of type 2 diabetes in overweight people by substantial weight loss is safe and hugely beneficial,” Professor O’Brien said. The research has been released today in the prestigious medical journal The Lancet Diabetes and Endocrinology.

Read more